FTXH vs PJP
First Trust Nasdaq Pharmaceuticals ETF against Invesco Pharmaceuticals ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
49%
16 shared positions
Fee gap
3 bp
PJP is cheaper
1-year return gap
11.2 pts
FTXH is ahead
Larger fund
FTXH
$1.1B
Side by side
| FTXH | PJP | |
|---|---|---|
| Fund | First Trust Nasdaq Pharmaceuticals ETF | Invesco Pharmaceuticals ETF |
| Issuer | First Trust | Invesco |
| Category | Health Care | Health Care |
| Expense ratio | 0.60% | 0.57% |
| Assets | $1.1B | $555M |
| Average daily dollar volume | $10M | $5.1M |
| Listed | Sep 20, 2016 | Jun 23, 2005 |
| FrenzyCap score | 51 | 49 |
| 1-month return | +1.8% | −1.5% |
| 3-month return | +7.9% | +4.5% |
| Year to date | +25.3% | +17.5% |
| 1-year return | +40.7% | +29.5% |
| 30-day volatility | 15.2% | 15.8% |
| Worst drawdown, 1 year | −7.5% | −9.7% |
| Trailing 12-month yield | 0.70% | 0.92% |
| Holdings | 51 | 31 |
| Top 10 weight | 53.1% | 50.2% |
| Look-through P/E | 43.5 | 428.7 |
| Holdings vs fair value | +7.5% | +10.7% |
| Holdings above 200-day average | 83% | 77% |
| Net flow, latest 3 reported months | +$3.3M thru Jun 2026 | +$86M thru Jul 2026 |
| 30-day implied volatility | 37.9% | 17.9% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
60% of FTXH · 67% of PJP
Sector mix of the stock holdings
| Sector | FTXH | PJP | Gap |
|---|---|---|---|
| Health Care | 92.7% | 99.9% | −7.2% |
| Technology | 2.8% | 0.0% | +2.8% |
More: full overlap table · FTXH holdings · PJP holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.